These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 20059824

  • 1. [Effects of the oxitetracycline in the increase of the packed cell volume of cows milk jugs during outbreak of bovine anaplasmosis].
    Gotze MM, Nizoli LQ, Silva SS.
    Rev Bras Parasitol Vet; 2008 Sep; 17 Suppl 1():92-5. PubMed ID: 20059824
    [Abstract] [Full Text] [Related]

  • 2. Outbreak of anaplasmosis associated with novel genetic variants of Anaplasma marginale in a dairy cattle.
    Aktas M, Özübek S.
    Comp Immunol Microbiol Infect Dis; 2017 Oct; 54():20-26. PubMed ID: 28915997
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of a new long-acting oxytetracycline formulation against anaplasmosis in colombian cattle.
    Todorovic RA, Gonzalez EF, Garcia O.
    Tropenmed Parasitol; 1979 Jun; 30(2):236-8. PubMed ID: 483386
    [Abstract] [Full Text] [Related]

  • 4. Bovine anaplasmosis: elimination of the carrier state with injectable long-acting oxytetracycline.
    Swift BL, Thomas GM.
    J Am Vet Med Assoc; 1983 Jul 01; 183(1):63-5. PubMed ID: 6874524
    [Abstract] [Full Text] [Related]

  • 5. Bovine anaplasmosis: clinical, hematologic, and serologic manifestations in cows given a long-acting oxytetracycline formulation in the prepatent period.
    Lincoln SD, Eckblad WP, Magonigle RA.
    Am J Vet Res; 1982 Aug 01; 43(8):1360-2. PubMed ID: 7103219
    [Abstract] [Full Text] [Related]

  • 6. Flow cytometric evaluation of selected antimicrobial efficacy for clearance of Anaplasma marginale in short-term erythrocyte cultures.
    Coetzee JF, Apley MD, Kocan KM, Jones DE.
    J Vet Pharmacol Ther; 2006 Jun 01; 29(3):173-83. PubMed ID: 16669861
    [Abstract] [Full Text] [Related]

  • 7. Comparison of the efficacy of enrofloxacin, imidocarb, and oxytetracycline for clearance of persistent Anaplasma marginale infections in cattle.
    Coetzee JF, Apley MD, Kocan KM.
    Vet Ther; 2006 Jun 01; 7(4):347-60. PubMed ID: 17216590
    [Abstract] [Full Text] [Related]

  • 8. Elimination of the carrier state of bovine anaplasmosis with a long-acting oxytetracycline.
    Roby TO, Simpson JE, Amerault TE.
    Am J Vet Res; 1978 Jul 01; 39(7):1115-6. PubMed ID: 677530
    [Abstract] [Full Text] [Related]

  • 9. Effectiveness of enrofloxacin for the treatment of experimentally-induced bovine anaplasmosis.
    Facury-Filho EJ, de Carvalho AÚ, Ferreira PM, Moura MF, Apolinário BC, Santos Lde P, Ribeiro MF.
    Rev Bras Parasitol Vet; 2012 Jul 01; 21(1):32-6. PubMed ID: 22534942
    [Abstract] [Full Text] [Related]

  • 10. Response of cattle upon reexposure to Anaplasma marginale after elimination of chronic carrier infections.
    Magonigle RA, Newby TJ.
    Am J Vet Res; 1984 Apr 01; 45(4):695-7. PubMed ID: 6731981
    [Abstract] [Full Text] [Related]

  • 11. Incidence and prevalence of tick-borne haemoparasites in domestic ruminants in Ghana.
    Bell-Sakyi L, Koney EB, Dogbey O, Walker AR.
    Vet Parasitol; 2004 Sep 20; 124(1-2):25-42. PubMed ID: 15350659
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Influence of a second Anaplasma exposure on the success of treatment to eliminate Anaplasma carrier infections in cattle.
    Kuttler KL.
    Am J Vet Res; 1983 May 20; 44(5):882-3. PubMed ID: 6869997
    [Abstract] [Full Text] [Related]

  • 14. Clinical features associated with seroconversion to Anaplasma marginale, Babesia bigemina and Theileria parva infections in African cattle under natural tick challenge.
    Magona JW, Walubengo J, Olaho-Mukani W, Jonsson NN, Welburn SC, Eisler MC.
    Vet Parasitol; 2008 Aug 17; 155(3-4):273-80. PubMed ID: 18579313
    [Abstract] [Full Text] [Related]

  • 15. Experimental bovine anaplasmosis: clinico-pathological and nutritional studies.
    Ajayi SA, Wilson AJ, Campbell RS.
    Res Vet Sci; 1978 Jul 17; 25(1):76-81. PubMed ID: 705052
    [Abstract] [Full Text] [Related]

  • 16. Ultrastructural and fluorochromatic changes of Anaplasma marginale exposed to oxytetracycline, imidocarb and enrofloxacin in short-term erythrocyte cultures.
    Coetzee JF, Kocan KM, Higgins JJ, Apley MD, Jones DE.
    Vet Microbiol; 2009 Apr 14; 136(1-2):45-53. PubMed ID: 19054634
    [Abstract] [Full Text] [Related]

  • 17. Elimination of naturally acquired chronic Anaplasma marginale infections with a long-acting oxytetracycline injectable.
    Magonigle RA, Newby TJ.
    Am J Vet Res; 1982 Dec 14; 43(12):2170-2. PubMed ID: 7165161
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Epidemiologic investigation and control of an epizootic of anaplasmosis in cattle in winter.
    Smith RD, Hungerford LL, Armstrong CT.
    J Am Vet Med Assoc; 1989 Aug 15; 195(4):476-80. PubMed ID: 2777688
    [Abstract] [Full Text] [Related]

  • 20. Effect of five daily intravenous treatments with oxytetracycline hydrochloride on the carrier status of bovine anaplasmosis.
    Magonigle RA, Renshaw HW, Vaughn HW, Stauber EH, Frank FW.
    J Am Vet Med Assoc; 1975 Dec 15; 167(12):1080-3. PubMed ID: 1194114
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.